NTPC Reports 34 Jump in Q4 Net Profit to 10615 Crore as Total Income Declines Costco Stock Surpasses 1000 Again Fueling Split Speculation Trump Reverses AI Executive Order Abruptly Drops Safety Review Requirement LG Energy Solution Shares Surge Up to 16 After Securing Major US Battery Storage Agreement CapitaLands 14 Billion Geneo Hub Aims to Reshape Singapores Life Sciences Landscape OpenAI Moves to the Forefront of the AI IPO Race Getting to Public Markets First Is Very Important FHI Q1 2026 Earnings EPS Surpasses Estimates by 63 Shares Edge Higher BWA Q1 2026 Earnings EPS Surpasses Estimates Amid Operational Focus NPCE Q1 2026 Earnings NarrowerthanExpected Loss Highlights Operational Discipline FICO Q1 2026 Earnings EPS Surges Past Expectations Amid Strong Scoring Business WHG Q1 2026 Earnings Earnings Per Share of 031 Amid Mixed Market Conditions TSHA Q1 2026 Earnings EPS Misses Estimates as Company Advances Gene Therapy Pipeline Verizon VZ Holds Steady Near Support as Trading Volume Remains Subdued Par Pacific Holdings PARR Holds Steady Near Midpoint as Energy Sector Consolidates Horizon Quantum Holdings Warrant HQWWW Surges 55 as Momentum Builds Distribution Solutions Group DSGR Shows Modest Uptick Amid Consolidation Gladstone Investment 4875 Notes GAINZ Stability Amidst Flat Trading Yield Opportunity in Focus Borosil Glass Works Shares Surge Over 200 in a Year on Strong Revenue Growth AMKR Q1 2026 Earnings Strong EPS Beat Amid Mixed Signals Stock Slightly Lower Baxter International BAX Edges Higher as Stock Consolidates Near Key Resistance VENU Q1 2026 Earnings Significant EPS Miss but Stock Surges 507 on Strategic Developments SXT Q1 2026 Earnings EPS Surges Past Estimates by 22 Shares Edge Higher MGRX Q3 2025 Earnings Narrowing Losses as Strategic Pivot Gains Momentum KURA Q1 2026 Earnings EPS Misses Estimates as ClinicalStage Biotech Navigates Development MNDO Q1 2025 Earnings EPS of 002 Reported as Stock Rises 133 VOYA Q1 2026 Earnings EPS Surpasses Estimates by 8 Amid Solid Underwriting and Fee Income ATYR Q1 2026 Earnings Narrower Loss Surprises as Biotech Advances Pipeline Without Revenue